Publication | Closed Access

Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis

HepatologyMedicineLiver PhysiologyNovel EvidencePathologyGut MicrobiotaHepatotoxicityLiver DiseaseHepatic SteatosisMicrobiologyFatty Liver DiseaseMetabolomicsIntestinal MicrobiotaPharmacologyMicrobiomeDrug-induced Liver Injury